U.S.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Current Report
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): January 29, 2016
PROLOGIS, INC.
PROLOGIS, L.P.
(Exact name of registrant as specified in its charter)
| Maryland (Prologis, Inc.) Delaware (Prologis, L.P.) |
001-13545 (Prologis, Inc.) 001-14245 (Prologis, L.P.) |
94-3281941 (Prologis, Inc.) 94-3285362 (Prologis, L.P.) | ||
| (State or other jurisdiction of incorporation) |
(Commission file number) |
(I.R.S. employer identification number) |
Pier 1, Bay 1, San Francisco, California 94111
(Address of principal executive offices) (Zip code)
415-394-9000
(Registrants’ telephone number, including area code)
n/a
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| ITEM 7.01 | Regulation FD Disclosure. |
On January 29, 2016, our chief executive officer and chairman of the board, Hamid R. Moghadam, adopted a pre-arranged 10b5-1 plan to exercise a portion of his vested stock options and sell the underlying shares received upon exercise of such options.
Mr. Moghadam is adopting such plan to exercise options that have expiration dates in 2019, 2020 and 2021. This 10b5-1 plan was adopted in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, and our policies regarding stock transactions.
Options to purchase up to 1,191,289 shares of our common stock may be exercised under Mr. Moghadam’s 10b5-1 plan. All transactions under his 10b5-1 plan will be disclosed publicly in filings with the U.S. Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrants have duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Prologis, Inc. | ||||||||
| (Registrant) | ||||||||
| Date: January 29, 2016 | By: | /s/ Michael T. Blair | ||||||
| Michael T. Blair | ||||||||
| Managing Director, Deputy General Counsel | ||||||||
| Prologis, L.P. | ||||||||
| (Registrant) | ||||||||
| By: | Prologis, Inc., Its general partner | |||||||
| Date: January 29, 2016 | By: | /s/ Michael T. Blair | ||||||
| Michael T. Blair | ||||||||
| Managing Director, Deputy General Counsel | ||||||||